Adding the arthritis drug tocilizumab to standard care for patients in hospital with severe or critical COVID-19 is no better than standard care alone in improving […]
A trial testing whether the arthritis drug tocilizumab plus standard care could improve outcomes for patients with severe or critical covid-19 has been stopped early after […]
Covid-19Skin rash is present in 17% of positive covid casesResearchers from King’s College, London compiled a catalogue of images of the most common skin manifestations of […]
Two large studies give a much sharper picture of which inherited mutations raise the risk of breast cancer for women without a family history of the […]